Related
Topics
Acronyms|
Clinical Research Dictionary
|
Diagnostic Terms |
Genes
|
General Abbreviations &
Acronyms
Lymphatic System |
Lymphoma
Simplified |
Our Immune System Terms
|
Remission & Response
Terms
| Treatment Background
|
AANS |
American Association of Neurological Surgeons |
|
ADCC |
Antibody-Dependent Cell-mediated Cytotoxicity.
Immune response triggered by presence of antibody, Abs, coating the
target cell, (such as Rituxan). |
|
Adenocarcinoma |
Tumor derived from glandular structures…present
within the mucosal linings…urinary tract… |
|
Adjuvant |
Auxilliary, added to improve action of that to
which it is added. |
|
Adrenal cortex |
Outer portion of adrenal glands, secrete
steroids that inhibit inflammation in allergic responses. |
|
Alemtuzumab |
Humanized monoclonal antibody, anti-CD52. Used
against CLL, et. al. |
|
Allele |
Any one of a series of two or more different
genes that occupy the same position(locus) on a chromosome. |
|
Allogeneic |
Referring to genetically different cell lines,
in one individual, capable of producing different antigens. |
|
AML |
Acute Myelogenous Leukemia or Acute Myeloid
Leukemia. |
|
Amyloid |
Glycoprotein deposited extracellularly in
tissues in amyloidosis. |
|
Amyloidosis |
Any of a variety of diseases that deposit
amyloid material in tissues. Primary has no obvious predisposing
condition. Secondary is associated with another chronic disease
such as TB. |
|
Anabolic |
Of, or related to, the synthetic phase of
metabolism. |
|
Anabolism |
Synthesis of more complex substances from
simpler ones. |
|
Analogue |
Chemical compound with a structure similar to
that of another but differing from it in respect to a certain
component; it may have a similar or opposite action metabolically. |
|
Aneuploidy |
One or a few chromosomes above or below the
normal chromosome number; e. g., three number 21 chromosomes, or
trisomy 21 (characteristic of Down Syndrome) is a form of aneuploidy. |
|
Anthracycline |
A type of antibiotic that comes from the fungus
Streptococcus peucetius. Some are daunorubicin, doxorubicin and
epirubicin. |
|
Antibody |
Immunoglobulin molecule evoked by an antigen
(immunogen). It interacts with the antigen, that induced its
synthesis, in some demonstrable way. |
|
Antigen |
Any substance, toxin or enzyme, that stimulates
the production of antibodies. |
|
Antigenicity |
Ability of a substance to trigger an immune
response to a particular organism. |
|
Antineoplastic |
Inhibiting or preventing development of
neoplasm, checking maturation and proliferation of malignant cells. |
|
Apheresis |
Peripheral blood stem cell harvesting. |
|
Apical |
Relating to apex or tip; situated near the apex
of a structure; opposite of basal. |
|
Apoptosis |
Ap-o-TOE-sis. A normal series of events in a
cell that leads to its death. |
|
Ascite |
Effusion and accumulation of serous fluid in
abdominal cavity; AKA abddominal or peritoneal dropsy,
hydroperitonea, and hydrops abdominis. |
|
Asthenia |
Weakness or debility. Syn: Adynamia |
|
Ataxia |
Failure of muscular coordination; irregularity
of muscular action. |
|
Atopic, atopy |
Clinical hypersensativity state or allergy with
a hereditary predisposition. The tendency is inherited, but the
specific clinical form (hay fever, asthma,…) is not. |
|
Autologous |
Produced from the subjects own tissues. |
|
BEAM |
BCNU (carmustine), cytarabine, etoposide,
melphalan. |
|
BID |
Twice a day (bis in die) |
|
Biliary |
Relating to bile or the biliary tract. |
|
Biotherapy |
Biological therapy. Treatment by injection of
substances that produce some biological reaction; antitoxins,
vaccines,… |
|
Cachexia |
ka kek' see a - Weight loss. |
|
Carcinoma |
Cancer that begins in the skin or tissues that
line or cover internal organs. |
|
Casuistry |
1. Application of general rules and principles
to questions of ethics or morals in order to resolve them. 2. Use
of subtle, sophisticated, and sometimes deceptive reasoning, esp. on
moral issues, in order to justify something or mislead somebody. |
|
CBCL |
Cutaneous B-Cell Lymphoma |
|
CCIR |
Center for Cancer Immunology Research |
|
Chimeric |
Composed of parts of different origin and are
seemingly incompatible (e. g.,mouse and human?) |
|
CHOP |
Cytoxan, Hydroxyrubicin (Adriamycin), Oncovin
(Vincristine), Prednisone |
|
Cisplatin |
Cis-isomer of a platinum compound that has
antineoplastic action and may enhance tumor antigenicity. |
|
CLL |
Chronic Lymphocytic Leukemia (Indolent) |
|
Cloaca |
Klo-aa'-ka In embryology, the terminal end of
the hindgut before division into rectum, bladder and genital
primordia. |
|
CML |
Chronic Myelogenous Leukemia |
|
CNOP |
Cycolphosphamide, Mitoxantrone, Vincristine
(Oncovin), Prednisone |
|
CNS |
Central Nervous System |
|
Cohort |
In epidemiology, a group of individuals who
share a common characteristic, statistical factor. The term always
indicates observation of the individuals over time. |
|
CPOP |
Pixantrone,
Cyclophosphamide,
vincristine (Oncovin),
and Prednisone. |
|
CR |
Complete Response |
|
CVP |
Chemo regimen of Cyclophosaphamide, Vincristine
and Prednisone. |
|
Cystectomy |
Surgical removal of the bladder. |
|
Cytokine |
A generic term for hormonelike, nonantibody,
low-molecular-weight proteins secreted by various cell types on
contact with specific antigens. They act as intercellular mediators,
as in the generation of an immune response. These are the
"interleukins". |
|
Cytology |
Study of cells, their origin, structure,
function and pathology. |
|
Cytolytic |
Having a destructive effect on cells. |
|
Cytoma |
General term for a cell tumour such as a
sarcoma. |
|
Cytopenia |
Reduction of the number of cells circulating in
the blood. |
|
Cytophotometry |
Study of organic compounds within cells by
measuring the light through selected stained areas of cytoplasm. |
|
Differentiation |
Maturity of cancer cells, ie, degree to which
they resemble normal cells. The more mature, ie, the closer the
resemblance, the slower growing and the better the prognosis. The
less the resemblance, the more uncontrollably they grow. |
|
Diplopia |
Perception of two images of a single object. |
|
Diuresis |
Increased production of urine. |
|
DLBCL |
Diffuse Large B-Cell Lymphoma |
|
DNA |
Deoxyribonucleic acid. Molecule of two long
strands that form a double helix and on which all genetic
information is encoded. |
|
Dyscrasia |
Disease or pathologic condition. |
|
Dyspnea |
Shortness of breath, a subjective difficulty or
distress in breathing. |
|
Dysuria |
Difficulty or pain in urination. |
|
Electrophoresis |
Separation of ionic molecules (principally
proteins) by the differential migration through a gel according to
the size and ionic charge of the molecules in an electrical field. |
|
Endocytosis |
Uptake of a material into a cell by the
formation of a membrane bound vesicle. |
|
Endogenous |
Originating or produced within the organism or
one of its parts. |
|
Endometrium |
The tissue lining of the uterus. |
|
Epistaxis |
Nosebleed. |
|
Epithelium |
Covering of internal and external surfaces of
the body. |
|
Epitope |
The simplest form of an antigenic determinant,
on a complex antigenic molecule, which can combine with antibody or
T-cell receptor. |
|
Erythema |
Redness due to capillary dilation. |
|
etiology |
The study of factors that cause disease and
their method of introduction to the host; causes or origin of a
disease or disorder. |
|
Extramedullary |
(Coupled with "haematopoiesis") The formation
and development of blood cells outside the bone marrow, as in the
spleen, liver or lymph nodes. |
|
Extramedullary plasmacytoma |
Monoclonal plasma cell infiltrate of tissues
other than bone. |
|
Febrile |
Fee-brul, Pertaining to fever. |
|
FISH |
Fluorescence in situ hybridization, a molecular
technique used in chromosome studies. The process vividly paints
chromosomes, or portions of chromosomes, with fluorescent molecules. |
|
Fistula |
Abnormal passage or connection. |
|
FL |
Follicular lymphoma, the most common form of
NHL. |
|
FLIPI |
Follicular Lymphoma International Prognostic
Index. Main purpose appears to be to characterize participants in
clinical trials. May, sometimes, be used in selecting treatments
and timing of treatments. |
|
Flow Cytometry |
Immunophenotyping method using fluorescently
labeled antibodies on specimen cells in fluid, forced through an
orifice, such that individual cells pass through a laser beam one at
a time. The cytometer counts the cells that fluoresce. |
|
FND |
Chemo regimen of Fludarabine, Mitoxantrone (Novantrone)
and dexamethasone. |
|
Fulguration |
Destroying tissue using an electric current. |
|
Gammopathy |
A condition of the immune system characterized
by an abnormal increase in the levels of immunoglobulins in the
blood. (See attachment) |
|
GBM |
Glioblastoma Multiforme (The most dangerous
type of brain tumor) |
|
Genotype |
The genetic constitution of an organism or
cell, as distinct from its expressed features or phenotype. |
|
HAMA |
Human Anti Mouse Antibody |
|
Hapten |
A molecule, incapable alone, of causing
production of antibodies, but can combine with a larger antigenic
molecule, a carrier. A heptan-carrier complex can stimulate
production of antibodies, some of which combine with the hapten
portion of the complex. |
|
Helminthic |
Pertaining to, or caused by, parasitic worms. |
|
Hematocrit |
Relative volume of blood occupied by
erythrocytes, i.e., red blood cells that carry oxygen to all parts
of the body. An avg figure for humans is 45 ml per cent, i.e., a
packed red cell volume of 45 ml in 100 ml of blood. |
|
Hematopoietic |
Pertaining to the formation of blood cells. |
|
Hematuria |
Presence of blood, or red blood cells, in the
urine. |
|
Hepatorenal |
hep a to ren' al Relating to the liver and
kidney. Syn: hepatonephric |
|
Hepatosplenomegaly |
Abnormal enlargement of both liver and spleen. |
|
Hepatoxicity |
Toxic to liver cells. |
|
Hilum (Hepatic) |
The part of an organ where the nerves and
vessels enter and leave. |
|
Histocompatibility |
Ability to be accepted and remain functional. |
|
Histology |
Study of cells and tissues at microscopic
level. |
|
Histology |
The microscopic appearance of biopsy cells. |
|
HLA |
Human Leukocyte Antigen. |
|
Homeostasis |
Tendency of a physiological system to remain
more or less stable. |
|
HPV |
Human Papillomavirus |
|
Hypercal'cemia |
Excessive amount of calcium in the blood. |
|
Hyperemic |
Increased amount of
blood flow
in a part or organ. |
|
Hyperuricemia |
Enhanced blood concentrations of uric acid. |
|
Idiopathic |
Cause unknown |
|
Idiotope |
Single antigenic determinant of an idiotype. |
|
Idiotype |
Collection of idiotopes that confers on Ig
molecule an antigenic individuality. Frequently a unique attribute
of a given antibody. A
unique cell marker. |
|
IFN |
Interferon |
|
IGIV |
Immune Globulin Intravenous. |
|
Immunogenic |
Evoking an immune response. Producing
immunity. |
|
Immunoglobulin |
A protein, produced by plasma cells, that acts
as an antibody fighting infections, allergens, tumors,… |
|
Immunopathogenesis |
Process whereby an immune response changes the
development of disease. |
|
Immunophenotype |
Specific repertoire of proteins displayed on
cell surface. |
|
Immunoscintigraphy |
Scintigraphy of antibodies labeled with
radioactive substances. |
|
Immunotherapy |
Treatment to stimulate immune system. A.K.A.
biological therapy, biotherapy, or biological response modifier (BRM)
therapy. |
|
In vitro |
In a glass, observable in a test tube. |
|
In vivo |
Within the living body. |
|
Inflammatory mediators Molecules released
by immune cells when harmful agents invade. |
|
Intrathecal |
Into the spinal fluid; into a sheath |
|
IPI |
International Prognostic Index. Predicts risk
of lymphoma recurrence and overall survival. Factors: age, stage,
general health, number of extranodal sites and LDH level. |
|
Karyotype |
Characterization of chromosomal complement of
an individual or species, including number, form and size of
chromosomes. |
|
Lamina Propria |
A thin vascular layer of connective tissue
beneath the epithelium of an organ. |
|
LDH |
Lactase dehydrogenase; enzyme in blood disease
indicator. |
|
Lesion |
Any pathological or traumatic discontinuity of
tissue or loss of function of a part. |
|
Leukopenia |
The antithesis of leukocytosis; any situation
in which the total number of leukocytes in the circulating blood is
less than normal, the lower limit of which is generally regarded as
4000 to 5000/mm^3. Syn: leukocytopenia. |
|
LLMPP |
Lymphoma/Leukemia Molecular Profiling Project. |
|
LPL |
Lymphoplasmacytic lymphoma. |
|
Lymphadenopathy |
Disease or swelling of the lymph nodes. |
|
Lymphocyte |
White cells, B (differentiate in bone marrow)
and T (differentiate in Thymus), for immune responses in the bodily
humors (fluids) and cells, respectively. |
|
Lymphokine |
Lim' fe kine, Substance released by T cells
that have been activated by enzymes. Activate macrophages. |
|
Lymphoma |
Neoplasm of lymph tissue, usually malignant. |
|
Lymphopenia |
A reduction, relative or absolute, in the
number of lymphocytes in the circulating blood. Syn: lymphocytic
leukopenia, lymphocytopenia. |
|
Lysis |
Rupture of cell membranes and loss of
cytoplasm. |
|
Lytic |
Pertaining to cell destruction (lysis). |
|
Macrophage |
A type of white cell that surrounds and kills
microorganisms, removes dead cells, and stimulates the action of
other immune cells. |
|
Malignant |
Tending to invade and destroy nearby tissue and
to spread to other parts of the body. Tending to become
progressively worse and to result in death. |
|
MCL |
Mantle cell lymphoma. |
|
MDS |
Myelodysplastic syndromes. |
|
Mediate |
To cause a change as in stimulation by a
hormone; accomplish by the aid of an intervening medium. |
|
Medulla |
The inner portion of an organ. |
|
Medullary |
Pertaining to the marrow or any medulla
resembling the marrow. |
|
Melanoma |
A form of skin cancer that arises in
melanocytes, the cells that produce pigment. Usually begins in a
mole. |
|
Mele'na (ee') |
Passage of dark colored, tarry stools, due to
blood altered by intestinal juices. |
|
Mesothelioma |
Malignant tumour of the mesothelium, usually of
lung, caused by exposure to asbestos fibres,… |
|
Mesothelium |
Single squamous epithelium of mesodermal
origin. It lines the peritoneal, pericardial and pleural cavities
and the synovial space of the joints. |
|
MGUS |
Monoclonal Gammopathy of Uncertain
Significance. |
|
MHC |
Major Histocompatibility Complex. The set of
gene loci specifying major histocompatibility antigens, e.g., HLA in
humans, DLA in dogs, H2 in mice, RLA in rabbits, RT1 in rats, SLA in
pigs, etc. |
|
Mitochondrion |
Mai-tE-kan-dri-En, Structures that occur in
nearly all cells of plants and animals, and that process food for
energy. |
|
Mitosis |
Also karyokinesis. Cell division. |
|
Moiety |
Moy'I tee; Any equal part; a half; also any
part or portion. |
|
Monoclonal |
Of a single clonal origin. |
|
Monocytopenia |
Abnormal decrease in the proportion of
monocytes in the blood. |
|
Morbidity |
A diseased state. The frequency of the
appearance of complications following a surgical procedure or other
treatment. |
|
Morphology |
The form or structure of a particular organism,
organ or part. |
|
Mucinous carcinoma |
A type of cancer that begins in cells that line
certain internal organs and produce mucin. |
|
Multiple Myeloma |
Uncontrolled growth of plasma cells, most
common primary malignant neoplasm of bone. |
|
Myalgia |
Muscular pain. Syn: Myodynia. |
|
Myeloablative |
Severe myelosuppression, i.e., suppression of
bone marrow activity. Reduces platelets, red cells and white
cells. [Myel(o)] pertains to bone marrow or spinal cord or myelin
(in this case, bone marrow). |
|
Myeloma |
Cancer that arises in plasma cells. |
|
Myelosuppression |
Bone marrow suppression, i.e., decrease in
hematopoietic activity. |
|
Myelotoxicity |
Destructive to bone marrow. |
|
NCI |
National Cancer Institute |
|
Neoplasia |
New growth, usually referring to abnormal new
growth and thus a tumor. |
|
Neoplasm |
New and abnormal growth of tissue which may be
benign or cancerous. |
|
Neoplastic |
Pertaining to or like a neoplasm with new and
abnormal growth. Pertaining to neoplasia with the formation of a
neoplasm. |
|
Neurogenic |
1. Forming nervous tissue. 2. Originating in
the nervous system or from a lesion in the nervous system. |
|
Neutropenia |
Decrease in number of neutriphils in the blood. |
|
NF |
Nuclear Factor. NF-kappaB is a protein
complex, transcription factor, associated with cellular immune
response and with cancer. |
|
NIH |
National Institutes of Health |
|
Nucleotide |
Basic structure of nucleic acid (RNA or DNA). |
|
Oligonucleotide |
A short polymer of two to twenty nucleotides. |
|
Oligosaccharide |
A saccharide of a small number of component
sugars. |
|
Oncogene |
A gene that causes the transformation of normal
cells into cancerous tumor cells. |
|
Oncogenic |
Causing the formation of tumors. |
|
Paramagnetic |
1. Magnetic as opposed to diamagnetic, which
means, repelled by the poles, positioning at right angles to
magnetic lines of force rather than behaving like ordinary magnetic
bodies such as iron. 2. Having a weak magnetic susceptibility. |
|
Paraprotein |
Abnormal monoclonal immunoglobulin
characteristic of, and produced by, malignant cells of the mature
B-cell type, e.g., multiple myeloma. |
|
Parenchyma |
The essential or functional elements of an
organ. |
|
Pathogenesis |
Source or development of a disease or disease
process;cellular events and reactions that occur during a disease
development. |
|
Pathology |
Medical study of disease, esp. changes in
tissues and organs that cause, or are caused by the disease. |
|
Pathway |
In the research papers we
see references to drugs that target PATHWAYS in cancer cells, which
can be intimidating because of the cryptic names given to these
unfamiliar functions within the cells, such as PI3K / Akt / mTOR.
Relating cell biology to automobile systems
(drive train, exhaust, electrical, fuel) might help to demystify …
at least it does for me.
Consider that the mechanic’s job is to diagnose
the problem – usually by first isolating it to the system most
likely to be causing the bad behavior, such as: is there a spark?
If no spark is seen, the problem is in the electrical "pathway."
And which part in the identified system? The
fuel pathway has a storage tank, fuel lines, filters, pumps, vacuum
hoses, and a carburetor - where air and fuel are mixed and then
injected into the cylinder where the combustion occurs (where the
spark meets the fuel) where one system or pathway meets the other.
So in the jargon of cellular biology, the fuel
tank is “upstream of” (comes before) the fuel line, which is
upstream of the carburetor and the cylinder where the combustion
occurs, and the exhaust system where the key event occurs (clearing
the chamber) and so on.
Similarly, we might read in a cancer research
paper: “Upstream signaling inhibition enhances rapamycin [the drug]
effect on growth of cancer cells” to mean: a narrowing or blockage
in the fuel line (upstream of the carburetor) caused the engine to
run slower or stop.
So while human cells are many times more
complex than the familiar combustion engine, there are some
conceptual similarities – sufficient to give us a feel for the
biology of abnormal cells and what the researchers are talking
about.
You don’t have to be a mechanic to effectively
drive a car, but it can help when you have a serious problem to have
a feel for the subject – as in: does this mechanic's proposed remedy
seem plausible?
And you don't need to be an mechanic - or even
familiar with the terms, to know if the theory worked ... your car
runs better or it doesn't; the treatment with the targeted drug
provides clinical benefit, or it doesn't, when tested in a trial.
"Mechanism is not evidence" even if proposed by the greatest
mechanic.
So when you read about a drug that targets the
XYZ pathway, keep in mind that it's just a name (made up by
somebody) for a system within a cell - which “drives” the bad
behavior of the cell - such as rapid cell division and a refusal to
shut down and die.
So, we might fairly substitute the
term “Automobile System” for “Cell Pathway” to feel more comfortable
when reading about and considering future cancer therapies. But for
those of us intimidated also by mechanical systems, I do get that we
will have to come up with another analogy. |
|
PCR |
Polymerase chain reaction. A technique by
which tiny amounts of DNA or RNA can be specifically identified. |
|
Perivascular |
Situated around or near a vessel. |
|
PET scan |
Positron Emission Tomography; images metabolic
activity of body tissues. |
|
Peyer's patches |
Areas of the intestinal wall which contain
normal MALT. |
|
Phagocyte |
A cell capable of phagocytosis. The main
mammalian phagocytes are neutrophils and macrophages. |
|
Phagocytic |
Pertaining to , or produced by, phagocytes. |
|
Phagocytosis |
Killing and digesting of particulate material
such as microorganisms. |
|
Phenotype |
The total characteristics displayed by an
organism under a particular set of environmental factors, regardless
of the actual genotype of the organism. Results from the
interaction between the genotype and the environment. |
|
phoresis (suffix) |
Transmission. |
|
Plasma cells |
White blood cells, produce antibodies. |
|
Plasmacytoma |
Cancer of the plasma cells, may turn into
multiple myeloma. |
|
Plasmaphoresis |
Process of separating certain cells from plasma
in the blood by machine; only the cells are returned to the
patient. Can be used to remove excess antibodies from the blood. |
|
Ploidy |
The number of sets of chromosomes within a cell
or organism. |
|
Pneumaturia |
Passage of gas in the urine, usually as the
result of a fistula between the bladder and intestine. |
|
poiesis |
A word termination meaning formation. |
|
PR |
Partial Response |
|
Progenitor` |
Parent or ancestor. |
|
Protease |
PRO-te-az, Enzymes that degrade protein
molecules, i.e., catalyze the hydrolytic breakdown into peptides or
amino acids. |
|
Proteolysis |
Cleavage of proteins by proteases. |
|
Proteolytic |
Pertaining to, characterized by or promoting
proteolysis. |
|
Pruritus |
Itching |
|
PTLD |
Post Transplant Lymphoproliferative Disease |
|
Purine |
Colorless crystalline heterocyclic compound
which is not found free in nature, but is variously substituted to
produce a group of compounds known as purines or purine bases of
which uric acid is a metabolic end product. The purine bases include
adenine and quanine, which are constituents of nucleic acids, and
hypoxanthine and xanthine. |
|
QD |
Once a day (quoque die) |
|
QID |
Four times daily |
|
R-CVP |
Rituximab, Cyclophosphamide, Vincristine,
Prednisone |
|
Reticuloendothelial |
Relating to the widely diffused bodily system
constituting all phagocytic cells except certain white blood cells. |
|
Retroperitoneum |
Retroperitoneal space. Space between the
perietal peritoneum and the muscles and bones of the posterior
abdominal wall. Contains kidneys, suprarenal glands, ureters,
duodenum, ascending and descending colon, pancreas, and the large
vessels and nerves. |
|
R-FCM |
Rituxan plus standard chemo of fludarabine,
cyclophosphamide and mitoxantrone. |
|
RNA |
Ribonucleic acid. A single strand molecule
that conveys DNA information to ribosomes to instruct synthesis of a
specific protein. Its sugar component of the nucleotides is ribose
vs deoxyribose of DNA. |
|
Sarcoma |
A form of cancer that arises in the supportive
tissues such as bone, cartilage, fat or muscle. |
|
Scintigraphy |
Diagnostic technique…two dimensional picture of
bodily radiation source obtained by use of radioisotopes. From
scintillation counter used to record radiation on the picture. |
|
Senescence |
State of growing old. Decay by time. |
|
Serology |
A blood test that detects the presence of
antibodies to a particular antigen. Branch of science concerned
with serum, esp. with specific immune or lytic serums; to measure
either antigens or antibodies in serum. |
|
SLL |
Small lymphocytic lymphoma. |
|
Somatic |
Any cell except a germ line cell. |
|
Splenomegaly |
Enlargement of the spleen. |
|
Squamous |
Scaly or platelike. |
|
Stasis |
Stoppage or cessation. |
|
Stem cell |
Cell that gives rise to a lineage of cells.
Most primitive cell found in bone marrow from what all various types
of blood cells are derived. A cell that, upon division, produces
dissimilar daughters, a replacement for the original and one that
differentiates further. |
|
Syngeneic |
Genetically identical, esp. w/ respect to
antigens or immunological reactions. |
|
Telomerase |
DNA enzyme that will elongate only
oligonucleotides from the telomere. |
|
Telomeres |
Tel' u mir, Either of sections of DNA occurring
at the ends of the chromosome. |
|
Thrombocyte |
Platelet. |
|
Thrombocytopenia |
Decrease in number of platelets in the blood. |
|
Thymocyte |
Lymphocyte found in the thymus; about 10% are
mature T, and rest immature precursors in various stages of
maturation. |
|
TID |
Three times daily (ter in die) |
|
TNF |
Tumor Necrosis Factor: Either of two (alpha or
beta) lymphokines, produced primarily by cells of the immune system,
capable of causing in vivo hemorrhagic necrosis of certain tumor
cells, but not normal cells. |
|
Transcription |
Synthesis of RNA by RNA polymerases using a DNA
template. |
|
Tumour |
Abnormal mass of tissue that results from
excessive cell division that is uncontrolled and progressive. Also
called "Neoplasm". |
|
Urine Immunofixation |
Special lab technique used to identify specific
proteins in the urine (or blood). Greatest application, identify
monoclonal proteins produced by conditions like Waldenstrom's
macroglobulinemia and multiple myeloma. |
|
Urotheliotrophic |
(Not in dictionaries) Relating to a
transitional wall of epithelium, in the bladder, and its nutrition. |
|
Urticaria |
(er' ti kar' ea) An eruption of itching wheals
(welts), usually of systemic origin. |
|
Vascular |
Characterized by, or containing, vessels for
carrying fluids, e.g., lymph or blood in animals or sap in plants. |
|
Vasogenic |
Pertaining to blood vessels. |
|
Vesical |
Relating to any bladder, usually the urinary
bladder. |
IMMUNE SYSTEM TERMS
A
B C D E F G H I
J K L M N O P Q R S T U V W X Y Z
active immunity
is an acquired immunity in which the immune system recognizes an
antigen as foreign and generates an attack on the invading pathogen or
abnormal cell that expresses the antigen (a unique protein
signature). The goal of cancer vaccines is to induce active
immunity against unique proteins specific to the tumor
cells. Here the immune system "learns" about the identity
of part of the tumor and "remembers" this information in order to
produce a sustained attack and long-term surveillance against the
cancer cells.
agammaglobulinemia - a deficiency or lack of
immunoglobulins, or antibody.
allergen - a substance that causes an
inappropriate reaction by the immune system to normally harmless
substances.
anaphylactic shock - a life threatening
allergic reaction causing swelling, difficulty breathing, and a drop
in blood pressure.
anergy - describes an unresponsive state of
immune cells to antigen stimulation.
adaptive Immunity (specific immunity) is a
response to a specific immune stimulus (antigen) that involves cells
of the immune system and frequently leads to a state of immune memory.
The adaptive immune system marshals antibodies and T cells that are highly specific for a particular
pathogen (or antigen). Once created, the antibodies and T cells can
eliminate the pathogen if it appears even years later - so-called
immune surveillance.
antibody (Ab) - a protein molecule (also called an immunoglobulin)
secreted by B cells in response to an
antigen (Ag). When an antibody attaches to an antigen, it destroys the antigen.
Antibody-dependent Cell-mediated Cytotoxicity (ADCC) - An
immune response triggered by the presence of antibody (Abs)
coating the target cell (such
as Rituxan).
Upon binding its antigen, the Antibody's Fc region is exposed and
will bind its receptor on the NK cell (or other effector cells) to form a bridge. Once the
bridge is formed, a poorly understood lytic (killing) signal is
delivered to the target cell by the effector cell, resulting in its demise. - (adapted from
the Merck Manual) Picture-it
antigen - the portion of a foreign substance or germ that can cause the immune system to become active against it.
Also from Merck Manual: "Substances that stimulate an immune
response in the body are called antigens. Antigens may be contained
within or on bacteria, viruses, other microorganisms, or cancer cells.
Antigens may also exist on their own—for example, as pollen or food
molecules. A normal immune response consists of recognizing a foreign
antigen, mobilizing forces to defend against it, and attacking
it."
antigen presenting cell (APC) - immune cells - such as b-cells,
macrophages, and dendritic cells - that recognize foreign
antigens, and present it to T-cells to initiate an immune
response.
antigen receptors - molecules on the surface
of b- and t-cells that allow the cells to engage a specific antigen in
the body in order to mount an immune response that is specific to the
foreign molecule it binds to.
antibiotics - Medicines used to treat some bacterial diseases.
apoptosis is
a natural mechanism by which cells "commit suicide" when
they have outlived their purpose, become defective, or have
aged. Apoptosis prevents cells from accumulating
and forming tumors. Understanding
of the control of apoptosis in normal and malignant cells will help to
improve the diagnosis and treatment of malignancies.
The goal of many treatments, including chemotherapies is to induce malignant
cells to undergo apoptosis. Picture
it
Analogy: Chances are you've seen a movie with apoptosis
as part of the plot ... in almost any James Bond film.
A fortress containing classified information is rigged for destruction
by the owners if the security of the building is compromised. The
process requiring a series of commands, which are relayed from one
authorized person to another. This to prevent a programmed
self-destruction by a careless mistake or a rouge individual.
The fail safe system is carried out from within by specialists, and
regulated by others. The trigger is not pulled until all the criteria
is met: the security threat is real and it can't be corrected; the
command has been given by authorized individuals and verified by
others, and the actions carried out by specialized personnel.
The security breach starts a chain of events (a cascade); each player
communicating to the other until the big red button is pushed and the
building destroyed; the sensitive information within it evaporating.
Similarly, our cells are rigged for self destruction when they become
old or defective. The main purpose is to protect the body against
replication of defective cells; and to remove old cells.
The program for cellular self-destruction is called apoptosis, which
is a type of quality control. The old or defective cells "take
one for the team." That some cells die and other live on to
replicate helps achieve a balance in the body. If individual cells
just replicated and never died, our organs would never cease growing.
What happens in a cancer cell is that some parts of the cell machinery
that carry out, signal for, or authorize apoptosis no longer function
... because of damage to genes that produce proteins that regulate or
carry out these functions.
Many chemotherapy treatments are designed to exploit apoptosis ... by
causing sufficient damage to the cells that force the issue,
magnifying the urgency to self-destruct. Waking up the components in
the cell that authorize apoptosis, such as the P53 gene.
One way the Rituxan might work is by changing the balance of signals
in the cells it binds to to favor apoptosis. Shifting the balance to
self destruct without causing damage. (Rituxan may also flag bound
cells for destruction by effector cells, which is not dependent on
apoptosis.)
Some investigational targeted agents are designed to wake up or
silence parts of the cell that carry out or block apoptosis. ...
Imagine that a key protein within the cell is overactive and is giving
a STOP order. Then imagine a small molecule drug that fits the shape
of this protein, stopping the STOP order. This class of drugs target
inhibitors of apoptosis. (Note: If normal cells utilize the same or
similar proteins to carry our normal cellular functions, you may
have side effects.) ~ KarlS
attenuated - no longer capable of causing
infection, as in an attenuated virus to make a vaccine. Also
means weakened.
autoantibody - an antibody that reacts against the body's own tissue.
autoimmune disease - a disease that results when the immune system mistakenly attacks the body's own tissues.
Examples: Rheumatoid arthritis, systemic lupus erythematosus, and type 1 diabetes.
b-cells (also called B lymphocytes) - a type of white blood cells that come from bone marrow and develop into plasma cells, mature B cells capable of producing
antibody. Each b-cell is capable of making an antibody specific to the
triggering antigen. The antigen trigger causing it to produce
numerous plasma cells capable of manufacturing the antibody.
biological marker (biomarker): A characteristic that is objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention.
www.fda.gov/cder/guidance/6400fnl.pdf
bronchi - airways in the lungs
CD (clusters of differentiation)- As b-cells
mature, they express different protein receptors on their surface. Some of these receptors
can be used as treatment targets. These proteins or antigen markers are called
Clusters of Differentiation (CD).
cell - building block that makes up tissues, organs, systems, and
blood of the body.
chemokines are molecules released by pathogens and infected tissues
that attract lymphocytes
chromosome - physical structure in a cell that contains genes. Almost every human cell has 23 pairs of chromosomes.
complement - a series of blood proteins whose action "complements" the work of antibodies. Complement destroys bacteria, produces inflammation, and regulates immune reactions.
complement-dependent cytotoxicity (CDC): A mechanism of killing
cells in which antibody bound to the target cell surface fixes
complement, which results in assembly of the membrane attack complex
that punches holes in the target cell membrane resulting in subsequent
cell lysis. Picture
it
cytokines are molecules released by cells to alter lymphocyte function.
DNA - Deoxyribonucleic acid - the basic instruction set for the development and activities of cells.
is like a library which contains thousands of books, called genes. DNA exists in all cells except mature erythrocytes. DNA is made up of bases (nucleotides) that are arranged in a specific sequence. The specificity of the sequence accounts for the production of a specific protein.
effector cells perform a specific function
in response to a stimulus; usually used to describe cells in the
immune system (such as NK- and Cytotoxic T-cells) that are
activated to kill a pathogen or a cancer cell. Also see
Antibody-dependent Cell-mediated Cytotoxicity above.
etiologies are the causes of disease.
epigenetic refers to the regulation of gene expression - how, when, where, how much, etc.. Two key areas of epigenetic control are and Chromatin
Remodeling and DNA Methylation.
epitope refers to the minimal
structural unit of an antigen, recognizable for antibodies and
lymphocyte antigenic receptors.
familial describes a trait or disease that is observed with higher frequency
within the same family, whether the etiology [cause] is genetic or environmental, or a combination of the two. Where a hereditary disease is
one that is caused by a genetic trait.
gene - a unit of genetic material that is inherited from a parent. A gene carries the directions a cell uses to perform a specific function, like making proteins. Genes are made of DNA, the basic chemical unit of life.
Genes contain the instructions or recipes for the creation (expression) of unique proteins that carry out
cellular functions, such as divide, migrate, or die.
germline mutation - a mutation (genetic
defect) that is inherited from your parents. Compare with a
somatic mutation, which is acquired by chance or by exposure to
toxins. The majority of cancers result from somatic mutations.
Graft vs Disease (GvD) - the action of donor cells against the
cancer cells following a stem cell translant.
Graft vs Host Disease (GvHD) - a sometimes
serious complication of stem cell transplants in which cells
from a donor attack organs of the body. Also see GvHD
granulocyte - a cell filled with potent chemicals that destroy germs and reduce inflammation.
hepatitis - a liver disease.
HLA stands for Human Leukocyte Antigens. These proteins
are unique markers found on the surface of nearly every cell in the
body, and are in especially high concentrations in white blood cells.
histiocytic -connective tissue containing large
white blood cells
humoral immunity - mainly involves b-cells,
with the cooperation of helper t-cells. Like macrophages,
b-cells take in and process antigens recognized as not belonging in
the body. Unlike macrophages, a b-cell can bind only to an
antigen that matches it's antibody receptor (idiotype). When
helper t-cell signals are present the antigen exposed b-cell will
multiply, and soon differentiate into plasma cells that create vast
quantities of identical antigen-specific antibodies. Released
into the blood, the antibodies lock onto matching antigens, which may
trigger complement-dependent cytotoxicity (CDC) and/or antibody-dependent
cell-mediated cytotoxicity (ADCC).
hypermethylation - [a term describing the activity
of genes] can cause oncogenes to produce proteins that cause malignant behavior.
Chromatin Remodeling - Protein fibers called histones that interact with DNA. Drugs that inhibit histone deacetylases, for example, may enable expression of tumor suppressor genes.
hyperplasia (hye-per-PLAY-zha) - An abnormal increase in the number of cells in an organ or tissue.
(source NCI)
hypomethylation - [ [a term describing the activity
of genes] can quiet genes that normally suppress cancer (tumor suppressor genes).
IgA, immunoglobulin A - a type of antibody concentrated in mucous membranes and body fluids like tears, saliva, and secretions of the respiratory and gastrointestinal tract.
IgG, immunoglobulin G - the major antibody found in the blood that can enter tissues. It coats germs, helping other cells to seek and destroy them.
IgM, immunoglobulin M - an antibody that remains in the bloodstream where it can kill bacteria that enter the blood stream.
immunoglobulins - a large family of proteins, also known as antibodies. There are five classes of immunoglobulins: IgA, IgM,
IgG, IgD, and IgE.
Picture-it
immune response - reactions of the immune system to foreign substances.
immune system - complex network of specialized cells and organs that has evolved to defend the body against attacks by foreign invaders.
immunity - protection from disease-causing microbes or pathogens.
immunization - the process of inducing protection (immunity) against the destructive forces of a disease-causing microbe.
immunoblastic - large lymphocyte that has been
stimulated by an antigen
Immunophenotyping:
tests that reveal the kinds of surface molecules that are present on
cells (typically immune cells), such as CD20, CD22. CDs stand
for clusters of differentiation, which show the developmental
stage of the cell and the cell type. CD20, for example, is
expressed only on mature b-cells, but not t-cells.
Innate immunity (non-specific immunity) -
consists of the pre-existing and fast-acting defenses of the body,
such as skin, mucous, cilia, cytokines, and other secretions. It
may be that innate immunity also emits signals that activate adaptive
immunity.
induction therapy typically consists of
conventional doses of chemotherapy administered in an attempt to
reduce the amount of cancer in a patient’s body prior to high-dose
therapy to be followed by a stem cell transplant.
infection - a state in which microorganisms have
taken residence and multiplied in body tissues.
inflammation - an immune system reaction to stop the progression of disease-causing microbes, sometimes seen at the site of an injury. Signs
of inflamation include redness, swelling, and heat.
leukemogenic* therapies. - * "The risk of leukemia was greatest four or five years after chemotherapy began, and the risk was elevated for at least eight years after the cessation of chemotherapy. The drugs cyclophosphamide, chlorambucil, melphalan, thiotepa, and treosulfan were independently associated with significantly increased risks of leukemia, as was the combination of doxorubicin hydrochloride and cisplatin. Chlorambucil and melphalan were the most leukemogenic drugs, followed by thiotepa; cyclophosphamide and treosulfan were the weakest leukemogens, and the effect per gram was substantially lower at high doses than at lower doses. The extent to which the relative risks of leukemia are offset by differences in chemotherapeutic effectiveness is not known."
http://content.nejm.org
lymph nodes - small bean-shaped organs of the immune system, distributed widely throughout the body.
They provide an
environment where lymphocytes can receive initial exposure to foreign
antigens (viruses, bacteria, fungi, etc.). This activates the
lymphocytes to perform immune functions. Most lymph nodes form
in clusters throughout the system, such as in the neck, armpit, and
groin.
lymphocytosis is an abnormal increase in the number of
lymphocytes — a type of white blood cell — in your blood. The most
common cause is viral infection, such as EBV, CMV, rubella, whooping
cough, toxoplasmosis, brucellosis, chronic lymphatic leukaemiam, and
leukemic phase lymphoma.
lymphoblastic - immature lymphocyte - white blood cell in
early stage of development.
lymphocytes - small white blood cells (B and T cells) that
provide immune defense.
neoplasia (NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.
(source NCI)
neutrophils - an important white blood cell that is both a phagocyte and a granulocyte abundant in the blood.
nodular - well-defined knot of tissue
macrophage - a large immune cell that
gobbles microbes and presents antigens from the ingested pathogen to
other immune cells. To further orchestrate an immune attack,
macrophages send protein signals none as monokines.
MHC molecules - At the heart of immunity is the ability of immune cells to distinquish self from none self. So a fundamental question is how do immune cells do this? Is it by shape? Color? Scent?
As it turns out cell-to-cell communication is a touchy/feely thing, and that when immune cells bump into other cells in the night they grope for a specific molecule called the MHC. Your immune cells can tell by
feeling for the distinctive structure of this molecule (it's protein signature) if it's one of your own ... so the correct MHC is a password for safe passage in your body.
The diversity of the MHC molecule from one individual to another is sometimes referred to as polymorphism, and this diversity that's encoded onto each cell of your body is the reason transplanted tissue is typically rejected.
"One group of proteins encoded by the genes of the MHC are the markers of self that appear in almost all body cells. Known as class I MHC antigens, these molecules alert killer t cells to the presence of body cells that have been changed for the worse - infected with a virus or transformed by cancer - and that need to be eliminated. "
"A second group of MHC proteins, class II antigens, are found on b cells, macrophages and other cells responsible for presenting foreign antigen to helper t cells. Class II products combine with particles of foreign antigen in a way that showcases the antigen and captures the attention of the helper t cells. "
Source: Understanding the Immune System ~ NIH
microbes - bacteria, fungi, or virus that invades
the body. Also called a pathogen.
molecule - The smallest physical unit made up of a chemical substance such as a protein or a fat. Molecules are the building blocks of a cell, and a gene determines how each molecule is produced.
mucous membrane - The moist lining of certain body cavities such as the mouth.
mutation - a change in a cell's DNA that may cause the cell to produce an abnormal protein.
methylation - is a hallmark of cancer. Specifically, it is the addition of a methyl group to specific cytosines (the components of DNA) that regulates gene activity.
oncogenes - mutated and/or over-expressed versions of normal genes that can cause a cell to lose growth restraints, fail to differentiate (mature to a next stage), or prevent the cell from initiating the programmed cell death process called apoptosis. Some oncogenes turn on other genes that promote cancer.
opsonization - a process that identifies cells or bacteria to
the phagocytic system (immune cells that engulf pathogens) that then
and attack and engulf cells or bacteria that have been identified to
them by the complement or antibody system.
opportunistic infections - infections caused by microbes that usually do not cause disease in healthy individuals, but which can result in overwhelming and widespread infection in people with immune deficiency.
palliative care - the goal is to
achieve the best possible quality of life for patients and their
families when the patients disease is not responsive to curative
treatment.
pathogen is a disease causing microorganism
phagocytes - large white blood cells that contribute to immune defense by engulfing microbes, such as bacteria and fungi, or other cells and foreign particles.
refractory is resistance to standard
treatment.
RNA - In order for DNA to produce a protein, an intermediate step is required. In this step, DNA is transcribed into RNA (messenger RNA, or mRNA). The sequence of mRNA that encodes a protein is oriented in only one direction, which is known as the "sense" orientation.
salvage therapy -- a term often applied to combinations of chemotherapy drugs
used to treat lymphomas after relapse in which the patient is either not
responsive to standard protocols, or the patient has general health
consideration (allergies, lung, or heart problems) that require the use of
unusual combinations of treatment agents, dosing or dosing schedules. Be
aware that despite the negative connotation of "salvage," these
novel treatments regimens can sometime achieve remissions.
somatic mutation - a mutation (genetic defect) which is
acquired by chance or by exposure to toxins. The majority of cancers
result from somatic mutations. Compare with germline mutations
that are inherited from your parents.
stem cell transplant (bone marrow transplant) - the goal of
this treatment is to cure the patient with aggressive therapies that
partially or completely kills off (ablates) the normal stem cells in
the marrow - the spongy tissue found in the cavities of the body's bones, where all the body's blood cells are produced.
These cells are then replaced with the patient's own stem cells
(harvested prior to treatment), or matched donor cells.
T cells (T lymphocytes) - white blood cells that either orchestrate the immune response (regulatory T cells) or directly attack infected or malignant cells (cytotoxic T cells).
tissue - a group of similar cells joined to perform the same function.
tissue type - the type of histocompatibility antigens on a person's cells or tissues. If the histocompatibility antigens do not match well, there is a much greater chance that the recipient will reject the donated tissue.
titers is a measurement of the concentration of a substance in
a solution. It usually refers to the amount of medicine or antibodies
found in a patient's blood.
tolerance is a non-reactivity of the immune system to self.
tumor suppressor genes - genes that protect cells from cancer. They may put the brakes on accelerated growth, or initiate cell death when DNA damage is detected. DNA damage. The under expression of tumor suppression genes can lead to malignant behavior.
vaccinal effect - when a therapy leads to recognition of tumor
antigens (abnormal proteins) as foreign leading to attack of remaining
tumors by t-cells.
vaccine - substance that contains parts of antigens from an infectious microbe. By stimulating an immune response (but not disease), it protects the body against subsequent infection by that organism. |